Bulik CC - Search Results

1

Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States.

Koomanachai P, Bulik CC, Kuti JL, Nicolau DP. Koomanachai P, et al. Among authors: bulik cc. Clin Ther. 2010 Apr;32(4):766-79. doi: 10.1016/j.clinthera.2010.04.003. Clin Ther. 2010. PMID: 20435246

2

In vivo efficacy of 1- and 2-gram human simulated prolonged infusions of doripenem against Pseudomonas aeruginosa.

Crandon JL, Bulik CC, Nicolau DP. Crandon JL, et al. Among authors: bulik cc. Antimicrob Agents Chemother. 2009 Oct;53(10):4352-6. doi: 10.1128/AAC.00282-09. Antimicrob Agents Chemother. 2009. PMID: 19770286 Free PMC article.

3

In vitro potency of CXA-101, a novel cephalosporin, against Pseudomonas aeruginosa displaying various resistance phenotypes, including multidrug resistance.

Bulik CC, Christensen H, Nicolau DP. Bulik CC, et al. Antimicrob Agents Chemother. 2010 Jan;54(1):557-9. doi: 10.1128/AAC.00912-09. Epub 2009 Nov 16. Antimicrob Agents Chemother. 2010. PMID: 19917762 Free PMC article.

4

Comparison of the activity of a human simulated, high-dose, prolonged infusion of meropenem against Klebsiella pneumoniae producing the KPC carbapenemase versus that against Pseudomonas aeruginosa in an in vitro pharmacodynamic model.

Bulik CC, Christensen H, Li P, Sutherland CA, Nicolau DP, Kuti JL. Bulik CC, et al. Antimicrob Agents Chemother. 2010 Feb;54(2):804-10. doi: 10.1128/AAC.01190-09. Epub 2009 Dec 7. Antimicrob Agents Chemother. 2010. PMID: 19995927 Free PMC article.

5

Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa.

Crandon JL, Bulik CC, Kuti JL, Nicolau DP. Crandon JL, et al. Among authors: bulik cc. Antimicrob Agents Chemother. 2010 Mar;54(3):1111-6. doi: 10.1128/AAC.01183-09. Epub 2009 Dec 28. Antimicrob Agents Chemother. 2010. PMID: 20038614 Free PMC article.

6

Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods.

Bulik CC, Fauntleroy KA, Jenkins SG, Abuali M, LaBombardi VJ, Nicolau DP, Kuti JL. Bulik CC, et al. J Clin Microbiol. 2010 Jul;48(7):2402-6. doi: 10.1128/JCM.00267-10. Epub 2010 May 19. J Clin Microbiol. 2010. PMID: 20484603 Free PMC article.

7

In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms.

Bulik CC, Tessier PR, Keel RA, Sutherland CA, Nicolau DP. Bulik CC, et al. Antimicrob Agents Chemother. 2012 Jan;56(1):544-9. doi: 10.1128/AAC.01752-10. Epub 2011 Nov 7. Antimicrob Agents Chemother. 2012. PMID: 22064538 Free PMC article.

8

Clostridium difficile infection--not just a burden anymore.

Bulik CC, Kuti JL, Nicolau DP. Bulik CC, et al. Conn Med. 2009 Aug;73(7):407-11. Conn Med. 2009. PMID: 19708320 Review. No abstract available.

9

In vivo efficacy of simulated human dosing regimens of prolonged-infusion doripenem against carbapenemase- producing Klebsiella pneumoniae.

Bulik CC, Nicolau DP. Bulik CC, et al. Antimicrob Agents Chemother. 2010 Oct;54(10):4112-5. doi: 10.1128/AAC.00026-10. Epub 2010 Jul 26. Antimicrob Agents Chemother. 2010. PMID: 20660688 Free PMC article.

10

Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysis.

Bulik CC, Wiskirchen DE, Shepard A, Sutherland CA, Kuti JL, Nicolau DP. Bulik CC, et al. Antimicrob Agents Chemother. 2010 Dec;54(12):5209-13. doi: 10.1128/AAC.01051-10. Epub 2010 Oct 4. Antimicrob Agents Chemother. 2010. PMID: 20921312 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page